Cefditoren pivoxil associated rash and arthralgia in a child

Manab Nandy1, Ananya Mandal, Santanu K Tripathi

  • 1Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, India. manabn@gmail.com

Insights

Cefditoren pivoxil, an antibiotic for pediatric infections, may cause rash and joint pain. Discontinuation led to full recovery, indicating a probable adverse drug reaction in this pediatric case study.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Pharmacology
  • Adverse Drug Reactions

Background:

  • Cefditoren pivoxil is an increasingly used oral antimicrobial for pediatric bacterial infections.
  • Adverse drug reactions (ADRs) in children require careful monitoring and assessment.

Purpose of the Study:

  • To report a case of rash and arthralgia associated with cefditoren pivoxil in a pediatric patient.
  • To assess the causality of the observed adverse event using standardized criteria.

Main Methods:

  • Case report of a four-year-old female child treated for lower respiratory tract infection.
  • Discontinuation of cefditoren pivoxil upon onset of symptoms.
  • Causality assessment using the WHO-UMC system and Naranjo's ADR probability scale.

Main Results:

  • The patient developed rash and arthralgia after cefditoren pivoxil administration.
  • Full recovery of knee joint function occurred within seven days of antibiotic discontinuation.
  • Causality was assessed as 'probable' by both WHO-UMC criteria and Naranjo's scale (score 7).

Conclusions:

  • Cefditoren pivoxil may be associated with adverse events such as rash and arthralgia in pediatric patients.
  • Prompt recognition and discontinuation of the antibiotic can lead to favorable outcomes.
  • This case highlights the importance of monitoring for ADRs with cefditoren pivoxil in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...